G. Sandra Karunya

G. Sandra Karunya

Auto-generated profile, based on publicly available information

G. Sandra Karunya


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 April 2026 in VFAST Transactions on Software Engineering
Verified
Journal Article
Closed access
VKV. Gokula Krishnan
V. Gokula Krishnan
SMShanker M.C
Shanker M.C
DKD. Arul Kumar
D. Arul Kumar
SKS. Kaviarasan
S. Kaviarasan
GKG. Sandra Karunya
G. Sandra Karunya
BLB. Prathusha Laxmi
B. Prathusha Laxmi
The drug discovery model for accelerating biomolecular interaction predictions employs sophisticated deep learning methodologies to recognize and foresee drug-target molecule interactions. This model makes use of large-scale databases such as GDSC and CCLE to increase the precision of the interaction mapping. Drug development is accelerated due to the time and cost savings. This paper proposes a modified One-Dimensional Convolutional Wasserstein Generative Adversarial Network (1D-CWGAN) for improving drug response prediction by tackling data imbalance in biomolecular datasets. The framework that is put forward mixes data augmentation using CWGAN with CNN and BiSRU based predictive models, alongside MGS-ROA for effective hyper parameter optimization. Employing sequential feature learning and stabilized adversarial training, the model produces top-notch synthetic samples that boost prediction stability. Tests carried out on GDSC and CCLE datasets show that the proposed CWGAN-BiSRU model is superior in performance, attaining RMSE values of 0.023 and 0.024, respectively, and higher correlation and determination coefficients than traditional machine learning, deep learning, and GAN-based methods. The findings reveal an improved ability to generalize and the efficiency of the proposed method for prediction of biomolecular interactions in drug discovery applications.